Welcome to our dedicated page for Kindly MD news (Ticker: KDLY), a resource for investors and traders seeking the latest updates and insights on Kindly MD stock.
Kindly MD, Inc. (NASDAQ: KDLY) is a pioneering, patient-first healthcare and data company dedicated to holistic pain management. The company integrates traditional primary care with behavioral health services and alternative therapies to address chronic pain and reduce opioid dependency. Kindly MD offers a range of specialty outpatient clinical services on a subscription and fee-for-service basis, including chronic pain management, functional medicine, cognitive behavioral therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Recent Achievements: On May 31, 2024, Kindly MD successfully priced its initial public offering, raising approximately $6.8 million in gross proceeds. The company issued 1,240,910 units at $5.50 per unit, each comprising one share of common stock and tradeable and non-tradeable warrants. These securities began trading on the Nasdaq Capital Market under the symbols KDLY and KDLYW, respectively.
Current Projects and Partnerships: Kindly MD has recently announced a strategic collaboration with Curaleaf Holdings, Inc., aimed at enhancing holistic pain management and medical cannabis education in Utah. This partnership will facilitate community care events and provide patients with access to comprehensive treatment plans, including medical cannabis, where appropriate.
Financial Condition: The funds raised from the IPO will strengthen Kindly MD's financial position, enabling further expansion of its services and enhancing its capability to offer innovative pain management solutions. The company continues to focus on sustainable growth and improving patient health outcomes.
Products and Services: Kindly MD's services include evaluation and management of chronic pain, functional medicine, cognitive behavioral therapy, and comprehensive recovery support. The company also provides medical cannabis education and recommendations as part of its holistic approach to pain management. As Utah's largest alternative pain treatment facility, Kindly MD emphasizes safe opioid use, appropriate dosing, and extensive behavioral health support to mitigate addiction risks.
Significance: Kindly MD is making significant strides in the healthcare industry by providing integrated pain management solutions and reducing opioid use. Its innovative approach and strategic partnerships position it as a leader in holistic healthcare, offering patients sustainable and safer treatment alternatives.
KindlyMD (NASDAQ:KDLY) has appointed Dr. Jeremy Joyal as Medical Director. Dr. Joyal, a licensed physician with board certifications in Anesthesiology, Pain Medicine, and Addiction Medicine, will oversee the company's clinical practices and develop program protocols for pain management. His responsibilities include ensuring adherence to current standards, implementing advanced pain management programs, and collaborating with healthcare providers to ensure comprehensive patient care across KindlyMD's platform.
Dr. Joyal's expertise is expected to enhance KindlyMD's clinical operations and patient care. He graduated from Brigham Young University with a degree in Neuroscience and earned his MD from the Medical College of Wisconsin. Dr. Joyal specialized in Anesthesiology at Washington University in St. Louis and completed a Pain Medicine fellowship at the University of Utah in 2014.
KindlyMD (NASDAQ: KDLY), a healthcare company integrating traditional primary care with pain management and alternative therapies, announces CEO Tim Pickett's participation in H.C. Wainwright's 26th Annual Global Investment Conference. The event will take place from September 9-11, 2024, at the Lotte New York Palace Hotel.
Key points:
- Pickett will present virtually and engage in one-on-one investor meetings
- The presentation will be available on-demand from 7:00 a.m. ET
- Investors can schedule meetings through H.C. Wainwright representatives or KCSA Strategic Communications
- A replay of the presentation will be accessible for at least 90 days on KindlyMD's investor website
This conference provides KindlyMD an opportunity to showcase its unique approach to healthcare and connect with potential investors.
KindlyMD (NASDAQ:KDLY) has appointed Nancy Pratt as Behavioral Health Program Director to enhance its Complete Care and Therapy services. Pratt, a clinical mental health counselor (CMHC) with over 10 years of experience, specializes in suicide assessment and treatment for anxiety, depression, and trauma. She holds a Master of Science in Clinical Mental Health Counseling from Westminster College and has a background in creating programs for at-risk youth.
CEO Tim Pickett emphasized that Pratt's expertise will be instrumental in designing and implementing the Complete Care program, which is central to KindlyMD's mission of delivering targeted, holistic healthcare. This appointment aligns with the company's strategy to integrate traditional primary care and pain management with behavioral and alternative therapies.
KindlyMD (NASDAQ:KDLY) announced its Q2 2024 financial results and provided a shareholder update. Key highlights include:
1. Nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers like Medicare, Select Health, Medicaid, and Blue Cross Blue Shield.
2. 163.7% sequential increase in reimbursement from insurance payors, totaling $126,325 in H1 2024 compared to $0 in H1 2023.
3. Completed IPO in June 2024 for net proceeds of $6.02 million.
4. Q2 2024 revenues decreased by 34.8% to $639,057, primarily due to a shift towards insurance billing.
5. Operating expenses increased by 6.0% to $1,676,250 in Q2 2024.
6. Net loss per share increased to $(0.26) in Q2 2024 from $(0.13) in Q2 2023.
7. As of June 30, 2024, cash and cash equivalents stood at $4.74 million with total working capital of $4.11 million.
KindlyMD (NASDAQ:KDLY), a healthcare and data company integrating traditional primary care with pain management and alternative therapies, has announced its participation in two upcoming investor conferences in August 2024:
1. Sidoti Micro-Cap Virtual Conference: Presenting on Wednesday, August 14th at 11:30 a.m. ET
2. Summer 2024 Investor Summit Virtual Conference: Presenting on Tuesday, August 20th at 12:30 p.m. ET
Both presentations will be available via webcast. Investors can schedule one-on-one meetings with KindlyMD's management team through Sidoti, Investor Summit Group, or by contacting KCSA Strategic Communications.
KindlyMD (NASDAQ:KDLY) has submitted a comment to the U.S. Department of Justice regarding the proposed reclassification of cannabis from Schedule I to Schedule III of the Controlled Substances Act. The company welcomes this potential change, which aligns with the growing recognition of cannabis's medical benefits. Key points:
1. Reclassification does not legalize marijuana federally.
2. It may reduce patient costs for medical cannabis products.
3. Cannabis businesses could deduct more expenses, potentially adding significant amounts to their balance sheets.
4. The change creates a more favorable business environment for KindlyMD, possibly enabling service expansion and reduced operational risks.
5. KindlyMD's integrated healthcare model remains relevant, particularly in providing medical cannabis education and evaluation in Utah.
KindlyMD, a healthcare company integrating primary care and pain management, announced its Q1 2024 financial results after its IPO on June 3, 2024.
Key highlights include:
- Revenue of $829,029, a 28.6% decrease from Q1 2023, due to a shift to insurance billing.
- First-time insurance reimbursements of $34,722, compared to $0 in Q1 2023.
- Operating expenses decreased by 21.9% to $1,066,156.
- Net loss per share reduced by 50% to $(0.06).
Post-IPO, KindlyMD raised $6.02 million, ensuring sufficient funding for the next 12 months. Additionally, the company secured contracts with major insurers, providing nearly 80% statewide coverage in Utah and plans to expand through acquisitions and marketing investments.
KindlyMD (NASDAQ: KDLY) has successfully registered on SAM.gov, enabling it to apply for and secure federal funds and contracts. On April 27, 2024, the company submitted its first grant application for the USDA’s Rural Utilities Service Distance Learning and Telemedicine (DLT) Grant Program, aiming to secure $1,000,000 to expand its Complete Care telehealth program in rural Utah. This initiative combines primary care, pain management, and mental health services. Successfully registering on SAM.gov paves the way for KindlyMD to pursue further grants, including SBIRT, ROTA, and MAT-PDOA, to enhance their comprehensive healthcare solutions.
KindlyMD (NASDAQ:KDLY), a healthcare firm integrating primary care, pain management, and alternative therapies, has contracted with Blue Cross Blue Shield, securing nearly 80% comprehensive insurance coverage statewide in Utah. The company is one of the first alternative medical treatment providers in Utah to achieve this status, adding to its existing contracts with Select Health, Medicare, and Medicaid. This expanded coverage is expected to increase patient volume and revenue across all clinics. Founded by Tim Pickett, PA-C, KindlyMD aims to address the opioid crisis by offering non-opioid treatments and medical cannabis education. To date, it has treated over 60,000 patients and remains dedicated to providing accessible, quality behavioral healthcare.
KindlyMD announced a strategic collaboration with Curaleaf to expand medical cannabis education in Utah. The partnership aims to offer holistic pain management and alternative therapies. Community care events will be held throughout the summer at Curaleaf's medical cannabis pharmacies in Lehi, Provo, and Payson. These events aim to educate patients on medical cannabis as a safer, more affordable option for pain management. KindlyMD's Complete Care program will be introduced, offering easier access to medical cannabis care. This initiative aligns with efforts to combat the opioid crisis and promote sustainable healthcare options.
FAQ
What is the current stock price of Kindly MD (KDLY)?
What is the market cap of Kindly MD (KDLY)?
What does Kindly MD, Inc. do?
What services does Kindly MD offer?
When did Kindly MD go public?
What is the stock symbol for Kindly MD?
What recent partnerships has Kindly MD announced?
How does Kindly MD integrate alternative therapies?
What are the financial benefits of the recent IPO?
Where can I find more information about Kindly MD's offerings?
What is Kindly MD's approach to opioid use?
Who is Kindly MD's partner in the recent collaboration?
